Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study. [electronic resource]
Producer: 20160620Description: 5217-24 p. digitalISSN:- 1873-2518
- Adolescent
- Antibodies, Bacterial -- blood
- Antigens, Bacterial -- immunology
- Australia
- Blood Bactericidal Activity
- Canada
- Child
- Complement System Proteins
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Immunization Schedule
- Male
- Meningococcal Infections -- immunology
- Meningococcal Vaccines -- administration & dosage
- Neisseria meningitidis, Serogroup B -- immunology
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.